Omniox is an IND-stage biotherapeutics company developing breakthrough H-NOX platform technology into first-in-class and best-in-class OMX oxygen delivery vehicles that treat a range of significant unmet medical needs. OMX biologics are engineered to deliver oxygen safely to hypoxic tissues, where abnormally low oxygen levels drive disease pathology and worsen patient outcomes. By specifically oxygenating pathologically hypoxic tissues, OMX biologics restore normal tissue function with the potential for improved outcomes and patient cures.